Wegovy 2.4 mg (Semaglutide) – Once-Weekly Pre-Filled Injection Pen (Novo Nordisk)

Wegovy 2.4 mg is an FDA-approved, prescription-only glucagon-like peptide-1 (GLP-1) receptor agonist used for long-term weight management. Containing semaglutide, this 2.4 mg dose serves as the standard recommended weekly maintenance strength for adults following a structured dose-escalation schedule. It works alongside a reduced-calorie diet and increased physical activity to help regulate appetite, reduce cravings, and support sustainable weight loss.

Wegovy belongs to the GLP-1 receptor agonist class and is administered once weekly for convenient weight management support. Clinical studies have shown significant weight reduction results when used consistently under medical supervision. Wegovy 2.4 mg is also approved to help reduce the risk of major cardiovascular events in eligible adults with obesity or higher weight and established heart disease.

 

Key Benefits & Medical Indications

Chronic Weight Management: Indicated for adults with obesity (BMI ≥30) or adults who are large in weight (BMI ≥27) with at least one weight-related condition like high blood pressure or type 2 diabetes.

Adolescent Support: Approved for pediatric patients aged 12 and older who meet specific age/sex BMI percentiles and weigh over 60 kg.

Cardiovascular Risk Reduction: Proven to reduce the risk of major adverse cardiovascular events (such as heart attack, stroke, or cardiovascular death) in adults with established heart disease and obesity/overweight.

Advanced Liver Health: Indicated to treat noncirrhotic metabolic dysfunction-associated steatohepatitis (MASH) with moderate-to-advanced liver fibrosis.

 

How Wegovy 2.4 mg Works

Wegovy mimics the body’s natural GLP-1 hormone. The active substance, semaglutide, targets receptors in the brain that control appetite and food intake. By slowing stomach emptying and signaling a feeling of fullness, it significantly decreases hunger and food cravings.

 

Usage & Administration Instructions

Frequency: Injected exactly once per week, on the same day each week, at any time of day.

Administration Method: Subcutaneous injection (under the skin) into the abdomen, thigh, or upper arm.

Diet & Exercise: Must be combined with a reduced-calorie meal plan and increased physical activity.

Flexibility: Can be administered with or without food.

 

Important Safety Information & Common Side Effects

Wegovy requires medical supervision and a valid prescription.

Common Side Effects: Mild-to-moderate gastrointestinal symptoms, including nausea, diarrhea, vomiting, constipation, and abdominal pain.

Boxed Warning: Wegovy carries a warning regarding the potential risk of thyroid C-cell tumors. Do not use if you or your family have a history of Medullary Thyroid Carcinoma (MTC) or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2).

 

Where to buy Wegovy 2.4 mg

Leafly Dispensary allows you to complete a digital medical questionnaire and text consultation with our licensed practitioners before shopping. If you qualify, we prescript and ship the medication directly to your door in temperature-controlled packaging.